Clinical Trials

27 enrolled

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

20 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07456189 2026-03-06

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

Other hematologic neoplasm

20 enrolled

Hematologic Neoplasms

NCT07426055 2026-02-23

PRO-BOOST-LC

Phase 2/3 Not yet recruiting

1,200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07414992 2026-02-17

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

44 enrolled

Urinary Bladder Neoplasms

NCT07393867 2026-02-06

ARPEGGIO

23 enrolled

Phase 3 Not yet recruiting

Prostatic Neoplasms

NCT07381660 2026-02-02

SBRT Versus Surgical Resection for Small HCC

312 enrolled

Carcinoma, Hepatocellular

NCT07379398 2026-01-30

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

28 enrolled

NSCLC

NCT07126158 2026-01-05

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

36 enrolled

Pancreatic Neoplasms

NCT07309952 2025-12-30

SACTION 2501

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07285538 2025-12-16

SBRTRC

60 enrolled

Kidney Neoplasms

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Phase 1 Not yet recruiting

Lung Neoplasms

NCT07075120 2025-10-28

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

15 enrolled

Carcinoma, Hepatocellular

NCT07189598 2025-09-24

ORION

390 enrolled

Prostatic Neoplasms

NCT07173387 2025-09-15

RAD-NALIRIFOX

42 enrolled

Pancreatic Neoplasms

NCT07152067 2025-09-03

TOPPGUN-RS

146 enrolled

Prostatic Neoplasms

NCT07132073 2025-08-27

MRI-guided Locoregional SBRT Prostate Program

40 enrolled

Prostatic Neoplasms

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

38 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07007728 2025-06-06

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

54 enrolled

Colorectal Neoplasms

NCT06991491 2025-05-28

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

29 enrolled

Phase 2/3 Not yet recruiting

Pancreatic Neoplasms

NCT06977061 2025-05-16

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression

30 enrolled

Stomach Neoplasms

NCT06592612 2024-09-19

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

70 enrolled

Carcinoma, Hepatocellular

NCT06363773 2024-08-28

RESTO-IMMUNO

Phase 1 Not yet recruiting

35 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06558175 2024-08-16

REPAIR

48 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06489821 2024-07-08

STAR-B

36 enrolled

Breast

Breast Neoplasms

NCT04571762 2024-05-23

Adaptive MR-guided SBRT for Localized Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT06422156 2024-05-20

Nim-PC-28

73 enrolled

Advanced Pancreatic Cancer

NCT06391008 2024-04-30

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

44 enrolled

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

96 enrolled

Locally Advanced Pancreatic Cancer

NCT05998993 2023-08-21

CULTRO

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05808790 2023-04-11

COPPER

394 enrolled

Lung Metastases

NCT05602974 2023-02-17

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

140 enrolled